Vitespen: a vaccine for renal cancer? (Q81583746)

scientific article published on 03 July 2008

Language	Label	Description	Also known as
English	Vitespen: a vaccine for renal cancer?	scientific article published on 03 July 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

title

Vitespen: a vaccine for renal cancer? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

author name string

James C Yang

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

language of work or name

English

0 references

publication date

3 July 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

volume

372

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

issue

9633

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

page(s)

92-93

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

cites work

An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960698-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960698-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960698-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960698-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960698-4

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(08)60698-4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

retrieved

10 January 2020

PubMed publication ID

18602687

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18602687

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18602687%20AND%20SRC:MED&resulttype=core&format=json

Vitespen: a vaccine for renal cancer? (Q81583746)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Vitespen: a vaccine for renal cancer? (Q81583746)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search